about
Pharmacologic resistance in colorectal cancer: a reviewEmerging therapeutic agents for lung cancerCurrent state of anti-PD-L1 and anti-PD-1 agents in cancer therapy.Genomic profiling of high-grade large-cell neuroendocrine carcinoma of the colon.Hairy Cell Lymphoma: A Potentially Under-Recognized Entity.Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience.Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
P50
Q26769850-9102FA6E-3E69-45D5-9122-276F6DA3C0B7Q28070165-F7C22DB0-0A3F-4874-9E4D-DF3271852E2CQ38369946-DD3A13BB-9EFE-4A52-B603-75183BF046B4Q38859321-5E3B63E5-09D9-4D5B-BF94-38BBA51BF279Q42292909-372AD506-6EB2-4F83-B01A-AE86CC05B23FQ52642462-8B588ECB-3F3E-4C61-B4E7-128C53303653Q91102653-80675F53-2AA7-4911-956C-FAA5E694A5F6
P50
description
investigador
@es
researcher
@en
name
William A Hammond
@en
type
label
William A Hammond
@en
prefLabel
William A Hammond
@en
P31
P496
0000-0002-7565-8558